EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study

Go back to EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 33.80 +0.21 (0.63%)
Previous Close $33.59    52 Week High $5.09 
Open $33.80    52 Week Low $1.11 
Day High $33.80    P/E N/A 
Day Low $33.80    EPS $0.00 
Volume 132